Mary T. Szela, CEO AND PRESIDENT at TriSalus Life Sciences, Inc. (TLSI), bought 49,542 shares at $5.12 ($50K) on 2025-01-28, disclosed to the SEC on 2025-01-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 40,000 | $0 | 0.0% |
| 2 | $5.42 | 4,826 | $26K | 52.0% |
| 3 | $5.12 | 4,716 | $24K | 48.0% |
| Total | $1.02 avg | 49,542 | $50K | 100% |
| Filing → |
| TLSI | SELL | 2026-03-20 | $79K | — | Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |